- Lobbying
- Bobby AND McMillin
Lobbying Arrangements Results for 'Bobby Mc Millin'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to federal funding for COVID-19 therapeutics. |
Rigel Pharmaceuticals Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to remote cardiac monitoring reimbursement cuts. |
BioTelemetry Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to higher education, workforce policy, and federal funding. |
Calbright College
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to patient access. |
Pharmacosmos Therapeutics Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to the expansion of the WTO TRIPS waiver for COVID-19 therapeutics. Issues related to access, coverage, and payment for ophthalmic drugs. Issues related to the coverage and federal f... |
Regeneron Pharmaceuticals, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to Medicare coverage and reimbursement of single-use endoscopy devices. |
EvoEndo, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in Ame... |
Grifols Shared Services North America, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to Medicare reimbursement of advanced wound care and surgical and sports medicine products. |
Organogenesis
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to domestic manufacturing of pharmaceuticals. |
Alvogen
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666). |
bluebird bio, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to federal policy for railways. |
Alaska - Alberta Railway Development Corporation
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to disease surveillance and pandemic preparedness, and the Pandemic All-Hazards Preparedness (PAHPA) reauthorization, including the Pandemic and All-Hazards Preparedness and Response... |
InductiveHealth Informatics
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to anti-hazing legislation, including support for the Stop Campus Hazing Act (H.R. 5646/S. 2901) and a resolution related to the designation of a National Hazing Awareness Week" (H.R... |
Fraternal Government Relations Coalition
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to pharmacy benefit managers and the 340B Program. Issues related to pharmacy benefit managers and the 340B program. Issues related to the clinical and overall benefit of anti-obesit... |
Novo Nordisk, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Policy issues related to student loans, including the student loan return to repayment and interest moratorium and other college affordability and student loan regulatory and legislative proposals,... |
Social Finance, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Funding for higher education programs related to research and evaluation within the FY 2024 AG (H.R. 4368/S. 2131), CJS (H.R. 5893/S. 2321), DOD (H.R. 4365/S. 2587), and LHHS (H.R 5894/S.2624). Pol... |
Baylor University
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to coordinated care models for childrens health, telehealth, the Childrens Health Insurance Program (CHIP), medical education, high-cost specialty drugs, pediatric mental health, hos... |
Childrens Health System of Texas
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369). |
Adaptive Biotechnologies
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to higher education policy, research, and development, including student financial aid, career development, teacher preparation, student veterans, coastal systems, and democracy refo... |
William & Mary Foundation
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to funding for pediatric mental health care, the Childrens Hospital Graduate Medical Education (CHGME) program, and Congressionally Directed Spending (CDS) and Community Project Fund... |
Children's Hospital of The King's Daughters
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to the manufacturing of infant formula and issues related to over-the-counter birth control. Issues related to the manufacturing of infant formula. |
Perrigo Company plc
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to access, coverage, a... |
Exelixis, Inc.
Oncology-focused biotechnology company |
Arnold & Porter Kaye Scholer LLP | |||
Details Policy issues relating to migrant services. Issues related to veterans medical, housing, and assistance services. CBP wellness and FEMA disaster case management. FY 24 appropriations regarding vete... |
Endeavors
|
Arnold & Porter Kaye Scholer LLP |